Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2008
11/12/2008CN101304999A Non-steroidal compounds useful as glucocorticoid receptor modulators
11/12/2008CN101304984A Oxazole and thiazole ppar modulator
11/12/2008CN101304978A Quinazoline derivatives as a multiplex inhibitor and method for the preparation thereof
11/12/2008CN101304975A P2X7 receptor antagonists and uses thereof
11/12/2008CN101304973A Methods of modulating neurotrophin-mediated activity
11/12/2008CN101304756A Herbal composition for inflammatory disorders
11/12/2008CN101302515A Human antibodies that bind human TNF(alpha)
11/12/2008CN101302243A 11-brominated-12-oleanane type pentacyclic triterpenoid and application thereof
11/12/2008CN101302221A Anti-platelet activating factor compound
11/12/2008CN101301475A Peg化因子vii糖型 Peg factor vii sugar type
11/12/2008CN101301460A Rheumatism paste for resolving stasis
11/12/2008CN101301452A Medicinal composition for treating gout and rheumatism
11/12/2008CN101301449A Antirheumatic medicinal liquor and preparation thereof
11/12/2008CN101301445A External-use powder for treating dermatopathy and paralysis
11/12/2008CN101301394A Medicament for treating rheumatoid disease
11/12/2008CN101301383A Quality control method of formulation for clearing wind-heat of children
11/12/2008CN101301370A Method for preparing monoester type alkaloids using Chinese medicinal material of aconitum as raw material
11/12/2008CN101301339A Babu far infrared medicinal plaster for treating arthralgia and myalgia, and wind-cold syndrome and numbness
11/12/2008CN101301307A Use of DFT in preparing medicament for treating and preventing sepsis
11/12/2008CN101301303A Uses of puerarin and derivatives thereof in preparing medicament
11/12/2008CN101301292A Medicament composition for preventing and treating infectious serositis of duck
11/12/2008CN101301083A Ginger tea capable of preventing and treating common cold
11/12/2008CN101301028A Chinese herbal medicine feed additive
11/12/2008CN100432107C Protein for promoting erythrocyte growth factor activity and its use
11/12/2008CN100432077C N-sulfonylaminothiazole
11/12/2008CN100432073C 6-alkoxy-pyrido-pyrimidines as p-38 MAP kinase inhibitors
11/12/2008CN100432070C Novel sulfamides and their use as endothelin receptor antagonists
11/12/2008CN100432062C Terphenyl derivatives, preparation thereof, compositions containing same
11/12/2008CN100432059C Quinazolinone derivatives useful as anti-hyperalgesic agents
11/12/2008CN100432055C Tricyclic protein kinase inhibitors
11/12/2008CN100432049C Cycloalkene derivatives, process for producing the same and use
11/12/2008CN100431604C C1 inhibitor with short half-life for transient treatment
11/12/2008CN100431588C Preparation of Chinese traditional medicine for treating disease of prolapse of intervertebral disc
11/12/2008CN100431576C Chinese materia medica preparation for treating pain in waist and lower extremities, and preparaton method
11/12/2008CN100431567C Use of delphinium glabra plant for preparing drug for stopping pain, hemostasis and anticancer
11/12/2008CN100431548C Chinese medicine composition for treating cold fever and liver damage and its preparing method
11/12/2008CN100431516C Device for calculating elixir doses approprate for patient's weight
11/11/2008US7449581 6-Substituted pyrido-pyrimidines
11/11/2008US7449576 potent antagonists of the CCR1 receptor; inflammation; (5-Chloro-2-piperazin-1-yl-phenyl)-phenyl-methanone
11/11/2008US7449495 e.g. 4-(3-(1-Adamantyl)-4-tert-butyldimethyl-silyloxyphenyl)benzaldehyde; antitumor, antiinflammatory agent; arthritic pathology, metastatisation, diabetic retinopathy, psoriasis, chronic inflammatory disease, and atherosclerosis; sarcoma, carcinoma, carcinoid, leukaemia
11/11/2008US7449493 N-[2-[[1-[[[(2,4-dimethylphenyl)methyl]amino]methyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide; monocyte chemoattractant proteins receptor antagonists or partial agonists/antagonists; antiinflammatory agent, autoimmune diseases; rheumatoid arthritis, multiple sclerosis, atherosclerosis
11/11/2008US7449492 Therapeutic agents—I
11/11/2008US7449490 Pharmaceutically active compounds and methods of use
11/11/2008US7449475 e.g. 2-{[(2S)-3-(5-Chloro-1'H,3H-spiro[1-benzofuran-2,4'-piperidin]-1'-yl)-2-hydroxypropyl]oxy}-N-cyclopropylbenzamide; macrophage inflammatory protein (MIP)-1 alpha chemokine receptor modulator; antiinflammatory, antiproliferative agent, autoimmune diseases
11/11/2008US7449446 Synergistic mixture; anticoagulants
11/11/2008US7449198 Stable salts of O-acetylsalicylic acid with basic amino acids
11/11/2008US7449185 Immunoglobulin which binds osteoclastogenesis inhibitory factor binding molecules (OBM)) and prevents bone resorption for use in treatment and prevention of bone disorders
11/11/2008US7449175 Delivery of erectile dysfunction drugs through an inhalation route
11/11/2008US7449174 Delivery of analgesics through an inhalation route
11/11/2008US7449172 Delivery of antiemetics through an inhalation route
11/06/2008WO2008133709A2 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production
11/06/2008WO2008133272A1 Medicated patch
11/06/2008WO2008133192A1 Fused imidazole compound and use thereof
11/06/2008WO2008133155A1 Bicyclic heterocyclic compound
11/06/2008WO2008132458A1 Compositions useful in the modulation of immune responses and the treatment or prevention of inflammatory responses and related methods
11/06/2008WO2008132453A1 Antibodies against ramp3
11/06/2008WO2008132025A1 Use of 4-(nitrooxy)-butyl-(s)-2-(6-methoxy-2-naphtyl)-propanoate for treating pain and inflammation
11/06/2008WO2008131946A2 Substituted amide derivatives
11/06/2008WO2008131922A1 New 4,8-diphenyl-polyazanaphthalene derivatives
11/06/2008WO2008131586A1 Uses of 5-methyl-1-(substituted phenyl)-2(1h)-pyridones as anti-inflammatory and tnf-alpha-blocking agents
11/06/2008WO2008113881B1 Compound that is a dual inhibitor of enzymes pde7 and/or pde4, pharmaceutical compositions and uses thereof
11/06/2008WO2008109361B1 Nucleic acid compounds for inhibiting erbb family gene expression and uses thereof
11/06/2008WO2008104473A3 Pyrazolopyriidine derivatives and their use as kinase inhibitors
11/06/2008WO2008100456A3 Functionally selective alpha2c adrenoreceptor agonists
11/06/2008WO2007127475A3 Pyridazines for demyelinating diseases and neuropathic pain
11/06/2008US20080275131 Compositions of (-)-e-10-oh-nt and methods for their synthesis and use
11/06/2008US20080275128 Contacting skin with X-ray contrast media such as iopamidol; sunscreen, cosmetics; colon disorders
11/06/2008US20080275127 Arylsulfonamido-substituted hydroxamic acid derivatives
11/06/2008US20080275125 Combination Composition
11/06/2008US20080275123 N-halogenated amino acid formulations
11/06/2008US20080275122 For contact lenses; surface treatment; respiratory disorders
11/06/2008US20080275117 Compositions and Methods Comprising Boswellia Species
11/06/2008US20080275092 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
11/06/2008US20080275088 Use of Collismycin and Derivatives Thereof as Oxidative Stress Inhibitors
11/06/2008US20080275063 C-{4-[6-(2-Ethoxy-phenyl)-pyrimidin-4-ylamino]-phenyl}-N-propyl-methanesulfonamide; antiinflammatories, antiproliferatives, analgesics; cardiovascular disorders, neurodegenerative diseases; immunotherapy
11/06/2008US20080275059 Novel physiologically active substances
11/06/2008US20080275053 Heterocyclyl Compounds
11/06/2008US20080275047 Tetrahydro-naphthalene derivatives
11/06/2008US20080275046 1-(3-{4-[4-(piperidin-1-ylmethyl)-1,3-oxazol-2-yl]phenoxy}propyl)piperidine; 4,4-difluoro-1-[(4-methyl-2-{4-[3-(2-methylpyrrolidin-1-yl)propoxy]phenyl}-1,3-thiazol-5-yl)carbonyl]piperidine; histamine H3-receptor antagonists; Parkinson's and Alzheimer's diseases; sleep disorders; antiepileptics
11/06/2008US20080275037 2-Cyanophenyl fused heterocyclic compounds, and compositions and uses thereof
11/06/2008US20080275033 Administering Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy
11/06/2008US20080275031 Inhibitors of C-FMS Kinase
11/06/2008US20080275028 Modulators or Alpha7 Nicotinic Acetylcholine Receptors and Therapeutic Uses Thereof
11/06/2008US20080275010 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
11/06/2008US20080275008 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus
11/06/2008US20080274998 Adjust biological activity of moesin by binding; parasiticides; bactericides; central nervous system disorders; Down's syndrome; antiinflamamtory agents; anticancer agents; autoimmune diseases; skin disorders; gastrointestinal disorders
11/06/2008US20080274993 Methods and compositions for modulating vascular integrity
11/06/2008US20080274498 Transgenic methylotrophic yeast for use as bioreactors in production of heterologous polypeptides
11/06/2008US20080274217 Oral Compositions and Route of Administration for the Delivery of a Thylakoid Extract
11/06/2008US20080274176 Pharmaceutical Lipid Compositions
11/06/2008US20080274167 Impermeable backing layer, an active substance layer of sufentanyl and a polymer mixture with microreservoirs dispersed, an active substance dissolved in the microreservoirs
11/06/2008US20080274131 Molecular antigen arrary
11/06/2008US20080274118 CD40 specific immunoglobulin for prevention and treatment of arthritic, cardiovascular, allergic, neurodegenerative and/or blood disorders
11/06/2008DE102007020690A1 Neue amorphe Form von 2-(4-Fluorophenyl)-4-3-hydroxy-3-mehtyl-1-butoxy)-6[4-methylsulfonyl)phenyl]-3(2H)-pyridazinon (FHMP) New amorphous form of 2- (4-fluorophenyl) -4-3-hydroxy-3-mehtyl-1-butoxy) -6 [4-methylsulfonyl) phenyl] -3 (2H) -pyridazinone (FHMP)
11/06/2008DE102007020689A1 Neue polymorphe Form von 2-(4-Fluorophenyl)-4-3-hydroxy-3-methyl-1-butoxy-5-[4-methylsulfonyl)phenyl]3/2H)-pyridazinon (FHMP) Novel polymorph of 2- (4-fluorophenyl) -4-3-hydroxy-3-methyl-1-butoxy-5- [4-methylsulfonyl) phenyl] 3 / 2H) -pyridazinone (FHMP)
11/06/2008DE102007020493A1 Substituierte Amid-Derivate Substituted amide derivatives
11/06/2008DE102007020492A1 Substituierte Sulfonamid-Derivate Substituted sulfonamide derivatives
11/06/2008CA2685503A1 Substituted amide derivatives
11/06/2008CA2685247A1 New 4,8-diphenyl-polyazanaphthalene derivatives
11/06/2008CA2685099A1 Antibodies against ramp3
1 ... 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 ... 1272